References

Stoopler ET Oral herpetic infections (HSV 1-8). Dent Clin North Am. 2005; 49:(1)15-29
Ghodratnama F, Wray D, Bagg J Detection of serum antibodies against cytomegalovirus, varicella zoster virus and human herpesvirus 6 in patients with recurrent aphthous stomatitis. J Oral Pathol Med. 1999; 28:(1)12-15
Renne R, Zhong W, Herndier B Lytic growth of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) in culture. Nat Med. 1996; 2:(3)342-346
Gnann JW Varicella-zoster virus: atypical presentations and unusual complications. J Infect Dis. 2002; 186:S91-98
Webster-Cyriaque J, Edwards RH, Quinlivan EB, Patton L, Wohl D, Raab-Traub N Epstein-Barr virus and human herpesvirus 8 prevalence in human immunodeficiency virus-associated oral mucosal lesions. J Infect Dis. 1997; 175:(6)1324-1332
Samonis G, Mantadakis E, Maraki S Orofacial viral infections in the immunocompromised host. Oncol Rep. 2000; 7:(6)1389-1394
Malkin JE Antiretroviral drugs for the treatment and prevention of herpes infections in the year 2000. Pathol Biol (Paris). 2002; 50:(8)477-482
Chayavichitsilp P, Buckwalter JV, Krakowski AC, Friedlander SF Herpes simplex. Pediatr Rev. 2009; 30:(4)119-129
Kolokotronis A, Doumas S Herpes simplex virus infection, with particular reference to the progression and complications of primary herpetic gingivostomatitis. Clin Microbiol Infect. 2006; 12:(3)202-211
Arduino PG, Porter SR Herpes Simplex Virus Type 1 infection: overview on relevant clinico-pathological features. J Oral Pathol Med. 2008; 37:(2)107-121
Wittek M, Doerr HW, Allwinn R Varicella and herpes zoster. Part 2: therapy and prevention. Med Klin (Munich). 2010; 105:(6)399-403
Oxman MN Zoster vaccine: current status and future prospects. Clin Infect Dis. 2010; 51:(2)197-213
Mustafa MB, Arduino PG, Porter SR Varicella zoster virus: review of its management. J Oral Pathol Med. 2009; 38:(9)673-688
Bravender T Epstein-Barr virus, cytomegalovirus, and infectious mononucleosis. Adolesc Med State Art Rev. 2010; 21:(5)251-264
Aberle SW, Mandl CW, Kunz C, Popow-Kraupp T Presence of human herpesvirus 6 variants A and B in saliva and peripheral blood mononuclear cells of healthy adults. J Clin Microbiol. 1996; 34:(12)3223-3225
Nikkels AF, Pierard GE Herpesvirus 6. What attention does it deserve in general practice?. Rev Med Liege. 2006; 61:(5-6)317-321
Stoeckle MY The spectrum of human herpesvirus 6 infection: from roseola infantum to adult disease. Annu Rev Med. 2000; 51:423-430
Braun DK, Dominguez G, Pellett PE Human herpesvirus 6. Clin Microbiol Rev. 1997; 10:(3)521-567
Ongradi J, Kovesdi V, Kovats E Human herpesvirus 7. Orv Hetil. 2010; 151:(16)645-651
Caselli E, Di Luca D Molecular biology and clinical associations of Roseoloviruses human herpesvirus 6 and human herpesvirus 7. New Microbiol. 2007; 30:(3)173-187
Ongradi J, Kovesdi V, Medveczky GP Human herpesvirus 6. Orv Hetil. 2010; 151:(13)523-532
Shiboski CH, Patton LL, Webster-Cyriaque JY The Oral HIV/AIDS Research Alliance: updated case definitions of oral disease endpoints. J Oral Pathol Med. 2009; 38:(6)481-488
Kabani S, Greenspan D, deSouza Y, Greenspan JS, Cataldo E Oral hairy leukoplakia with extensive oral mucosal involvement. Report of two cases. Oral Surg Oral Med Oral Pathol. 1989; 67:(4)411-415
Mendoza N, Diamantis M, Arora A Mucocutaneous manifestations of Epstein-Barr virus infection. Am J Clin Dermatol. 2008; 9:(5)295-305
Mesri EA, Cesarman E, Boshoff C Kaposi's sarcoma and its associated herpesvirus. Nat Rev Cancer. 2010; 10:(10)707-719
Taylor GS, Blackbourn DJ Infectious agents in human cancers: lessons in immunity and immunomodulation from gammaherpesviruses EBV and KSHV. Cancer Lett. 2011; 305:(2)263-278
Cleveland JL, Junger ML, Saraiya M, Markowitz LE, Dunne EF, Epstein JB The connection between human papillomavirus and oropharyngeal squamous cell carcinomas in the United States: implications for dentistry. J Am Dent Assoc. 2011; 142:(8)915-924
Syrjanen S, Lodi G, von Bultzingslowen I Human papillomaviruses in oral carcinoma and oral potentially malignant disorders: a systematic review. Oral Dis. 2011; 17:58-72
D'Souza G, Fakhry C, Sugar EA Six-month natural history of oral versus cervical human papillomavirus infection. Int J Cancer. 2007; 121:(1)143-150
D'Souza G, Kreimer AR, Viscidi R Case-control study of human papillomavirus and oropharyngeal cancer. N Engl J Med. 2007; 356:(19)1944-1956
Mannarini L, Kratochvil V, Calabrese L Human Papilloma Virus (HPV) in head and neck region: review of literature. Acta Otorhinolaryngol Ital. 2009; 29:(3)119-126
D'Souza G, Dempsey A The role of HPV in head and neck cancer and review of the HPV vaccine. Prev Med. 2011; 53:S5-S11
Leao JC, Ribeiro CMB, Carvalho AAT, Frezzini C, Porter S Oral complications of HIV disease. Clinics (Sao Paulo). 2009; 64:(5)459-470
Scott LA, Stone MS Viral exanthems. Dermatol Online J. 2003; 9:(3)
Moss WJ, Griffin DE Measles. Lancet. 2012; 379:(9811)153-164
Sabella C Measles: not just a childhood rash. Cleve Clin J Med. 2010; 77:(3)207-213
Coloe J, Burkhart CN, Morrell DS Molluscum contagiosum: what's new and true?. Pediatr Ann. 2009; 38:(6)321-325
Slots J Oral viral infections of adults. Periodontol 2000. 2009; 49:60-86
Hille JJ, Webster-Cyriaque J, Palefski JM, Raab-Traub N Mechanisms of expression of HHV8, EBV and HPV in selected HIV-associated oral lesions. Oral Dis. 2002; 8:161-168
Purgina B, Pantanowitz L, Seethala RR A review of carcinomas arising in the head and neck region in HIV-positive patients. Patholog Res Int. 2011; 2011 https://doi.org/10.4061/2011/469150

Orofacial viral infections – an update for clinicians

From Volume 41, Issue 6, July 2014 | Pages 518-524

Authors

Raj G Nair

MSc, PhD, MRACDS(Oral Med)

Oral Medicine, School of Dentistry and Oral Health, Centre for Medicine and Oral Health, Griffith Health Institute, Griffith University and Department of Haematology and Oncology, Gold Coast Hospital

Articles by Raj G Nair

Ali Salajegheh

MD, PhD

School of Medicine, Centre for Medicine and Oral Health, Griffith Health Institute, Griffith University

Articles by Ali Salajegheh

Anut Itthagarun

DDS, PhD, PDipDS(Paed Dent)

Paediatric Dentistry, School of Dentistry and Oral Health, Centre for Medicine and Oral Health, Griffith Health Institute, Griffith University

Articles by Anut Itthagarun

Sahar Pakneshan

MD

School of Medicine, Centre for Medicine and Oral Health, Griffith Health Institute, Griffith University, Gold Coast, Queensland, Australia

Articles by Sahar Pakneshan

Michael T Brennan

DDS, MHS, FDS RCS(Edin)

Department of Oral Medicine, Carolinas Medical Center, Charlotte, NC, USA

Articles by Michael T Brennan

Lakshman P Samaranayake

DSc(hc), DDS(Glas), FDS RCSE(Hon), FRCPath(UK)

Chair Professor of Oral Microbiology and Dean, Faculty of Dentistry, the University of Hong Kong, Hong Kong

Articles by Lakshman P Samaranayake

Abstract

Orofacial viral infections may be less common but appear in different clinical forms. Often these infections get initially treated by antibiotics which obviously will have limited or no effect. The authors review the current concepts of orofacial viral infections, causative agents, their classification and clinical manifestations and a basis for treatment.

Clinical Relevance: Most viral infections do not require any specific treatment except in patients who are immunosuppressed or immunodeficient. Appropriate diagnosis and timely management of orofacial viral lesions are important irrespective of whether it is localized or a manifestation of a systemic infection.

Article

Patients often present with orofacial infections in general medical and dental practice. These infections may be caused by bacterial, fungal or viral pathogens. Viral infections may manifest in different clinical forms and affect all age groups. The most common viral infection affecting the orofacial region is caused by the herpes simplex virus (HSV). Infection from a virus follows a different aetiopathogenic pathway compared with bacteria, fungi and other organisms, as a virus metabolism is dependent on host cells. In general, most of the viral infections of the orofacial region are self-limiting in an otherwise healthy individual, whilst compromised individuals may present with a myriad of local and systemic complications of viral infections.

General dental practitioners should be aware of the wide range of clinical manifestations of viral infections, which may affect the orofacial region as a localized disease or a manifestation of a systemic viral infection, such as the human immunodeficiency virus (HIV) disease. The aim of this short review is to provide a state-of-the-art, concise account of orofacial viral infections of humans and their management.

Register now to continue reading

Thank you for visiting Dental Update and reading some of our resources. To read more, please register today. You’ll enjoy the following great benefits:

What's included

  • Up to 2 free articles per month
  • New content available